Prescription drug giant GlaxoSmithKline agreed to pay a record $3 billion fine to settle a litany of charges stemming from the company's illegal promotion of its products. Among other criminal complaints, federal prosecutors had accused GlaxoSmithKline of promoting the anti-depression drug Paxil for children, even though the FDA had never approved Paxil for patients under 18. GlaxoSmithKline was also accused of bribing physicians to prescribe its products, part of a web of mutual back-scratching that critics say has compromised the prescription drug market.
THE WEEK'S AUDIOPHILE PODCASTS: LISTEN SMARTER
- The U.S. Marines are developing laser weapons. Here's why.
- 43 TV shows to watch in 2014
- How to be the most productive person in your office — and still get home by 5:30 p.m.
- Why the Supreme Court is allowing Texas to hold an unconstitutional election
- 3 horrific inaccuracies in Homeland's depiction of Islamabad
- How 1,000-year lifespans could remake the economy
- Ban PowerPoint!
- 6 things the happiest families all have in common
- Gamergate has backfired spectacularly on its nincompoop perpetrators
- It's time to kill school picture day
Subscribe to the Week